Robert Andrew Douglas - 17 May 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO ResMed Inc.
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
17 May 2021
Net transactions value
-$1,094,080
Form type
4
Filing time
19 May 2021, 12:49:20 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $1,560,000 -8,000 -48% $195.00 8,766 17 May 2021 Direct F1
transaction RMD ResMed Common Stock Options Exercise $465,920 +8,000 +91% $58.24 16,767 17 May 2021 Direct F1, F2
holding RMD ResMed Common Stock 210,407 17 May 2021 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -8,000 -5.3% $0.000000 142,098 17 May 2021 ResMed Common Stock 8,000 $58.24 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes 65.09 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan.
F3 Represents date options first became exercisable. Options vest 1/3 per year.